{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T04:12:21Z","timestamp":1684555941092},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Clin Oncol"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1038\/nrclinonc.2009.87","type":"journal-article","created":{"date-parts":[[2009,6,29]],"date-time":"2009-06-29T07:18:29Z","timestamp":1246259909000},"page":"380-382","source":"Crossref","is-referenced-by-count":1,"title":["ASCT in follicular lymphoma"],"prefix":"10.1038","volume":"6","author":[{"given":"Jennifer R.","family":"Brown","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnold S.","family":"Freedman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BFnrclinonc200987_CR1","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1182\/blood-2008-05-160200","volume":"113","author":"E Gyan","year":"2009","unstructured":"Gyan, E.  et al. High-dose therapy followed by autologous purged stem cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by the GOELAMS with final results after a median follow-up of 9 years. Blood 113, 995\u20131001 (2009).","journal-title":"Blood"},{"key":"BFnrclinonc200987_CR2","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1182\/blood-2004-03-0982","volume":"104","author":"G Lenz","year":"2004","unstructured":"Lenz, G.  et al. Myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission prolongs progression-free survival in follicular lymphoma: results of a prospective, randomized trial of the German Low-Grade Lymphoma Study Group. Blood 104, 2667\u20132674 (2004).","journal-title":"Blood"},{"key":"BFnrclinonc200987_CR3","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1182\/blood-2006-03-013193","volume":"108","author":"C Sebban","year":"2006","unstructured":"Sebban, C.  et al. Standard chemotherapy with interferon compared with CHOP followed by high-dose therapy with autologous stem cell transplantation in untreated patients with advanced follicular lymphoma: the GELF-94 randomized study from the Groupe d'Etude des Lymphomes de l'Adulte (GELA). Blood 108, 2540\u20132544 (2006).","journal-title":"Blood"},{"key":"BFnrclinonc200987_CR4","doi-asserted-by":"publisher","first-page":"3614","DOI":"10.1200\/JCO.2007.15.5358","volume":"26","author":"C Sebban","year":"2008","unstructured":"Sebban, C.  et al. Impact of rituximab and\/or high-dose therapy with autotransplant at time of relapse in patients with follicular lymphoma: a GELA study. J. Clin. Oncol. 26, 3614\u20133620 (2008).","journal-title":"J. Clin. Oncol."},{"key":"BFnrclinonc200987_CR5","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1200\/JCO.2005.05.158","volume":"23","author":"JR Brown","year":"2005","unstructured":"Brown, J. R.  et al. Increasing incidence of late second malignancies after conditioning with cyclophosphamide and total-body irradiation and autologous bone marrow transplantation for non-Hodgkin's lymphoma. J. Clin. Oncol. 23, 2208\u20132214 (2005).","journal-title":"J. Clin. Oncol."},{"key":"BFnrclinonc200987_CR6","doi-asserted-by":"publisher","first-page":"3817","DOI":"10.1182\/blood-2004-10-3920","volume":"105","author":"E Deconinck","year":"2005","unstructured":"Deconinck, E.  et al. High-dose therapy followed by autologous purged stem-cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by GOELAMS. Blood 105, 3817\u20133823 (2005).","journal-title":"Blood"},{"key":"BFnrclinonc200987_CR7","doi-asserted-by":"publisher","first-page":"4004","DOI":"10.1182\/blood-2007-10-116749","volume":"111","author":"M Ladetto","year":"2008","unstructured":"Ladetto, M.  et al. Prospective, multicenter randomized GITMO\/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular lymphoma at diagnosis: the superior disease control of R-HDS does not translate into an overall survival advantage. Blood 111, 4004\u20134013 (2008).","journal-title":"Blood"},{"key":"BFnrclinonc200987_CR8","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/j.bbmt.2007.05.012","volume":"13","author":"JR Brown","year":"2007","unstructured":"Brown, J. R.  et al. Long-term survival after autologous bone marrow transplantation for follicular lymphoma in first remission. Biol. Blood Marrow Transplant. 13, 1057\u20131065 (2007).","journal-title":"Biol. Blood Marrow Transplant."},{"key":"BFnrclinonc200987_CR9","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.1200\/JCO.2006.09.8327","volume":"25","author":"AZ Rohatiner","year":"2007","unstructured":"Rohatiner, A. Z.  et al. Myeloablative therapy with autologous bone marrow transplantation for follicular lymphoma at the time of second or subsequent remission: long-term follow-up. J. Clin. Oncol. 25, 2554\u20132559 (2007).","journal-title":"J. Clin. Oncol."},{"key":"BFnrclinonc200987_CR10","doi-asserted-by":"publisher","first-page":"3918","DOI":"10.1200\/JCO.2003.10.023","volume":"21","author":"HC Schouten","year":"2003","unstructured":"Schouten, H. C.  et al. High-dose therapy improves progression-free survival and survival in relapsed follicular non-Hodgkin's lymphoma: results from the randomized European CUP trial. J. Clin. Oncol. 21, 3918\u20133927 (2003).","journal-title":"J. Clin. Oncol."}],"container-title":["Nature Reviews Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrclinonc.2009.87.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrclinonc.2009.87","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrclinonc.2009.87.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:03:47Z","timestamp":1684469027000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrclinonc.2009.87"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":10,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["BFnrclinonc200987"],"URL":"https:\/\/doi.org\/10.1038\/nrclinonc.2009.87","relation":{},"ISSN":["1759-4774","1759-4782"],"issn-type":[{"value":"1759-4774","type":"print"},{"value":"1759-4782","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}